Related Experiment Video
Updated: Aug 9, 2026
08:43
Simultaneous Measurement of Mitochondrial Calcium and Mitochondrial Membrane Potential in Live Cells by Fluorescent Microscopy
Published on: January 24, 2017
Mitochondrial uncoupling proteins as potential targets for pharmacological agents
Mary-Ellen Harper1, Martin F Gerrits
1Department of Biochemistry, Microbiology and Immunology, Faculty of Medicine, University of Ottawa, Ottawa, Canada. MaryEllen.Harper@uottoawa.ca
Current Opinion in Pharmacology
|November 5, 2004
Summary
The original uncoupling protein (UCP1) facilitates thermogenesis. Novel uncoupling proteins (UCP2-UCP5) have poorly understood functions, potentially involving reactive oxygen species and fatty acid metabolism, with distinct roles from UCP1.
Area of Science:
- Mitochondrial biology
- Biochemistry
- Physiology
Background:
- The function of uncoupling protein 1 (UCP1) in thermogenesis is well-established.
- Novel uncoupling proteins (UCP2-UCP5) have emerged, but their mechanisms and physiological roles remain largely unknown.
- These proteins belong to the mitochondrial anion carrier family.
Purpose of the Study:
- To elucidate the poorly understood functions of novel uncoupling proteins (UCP2-UCP5).
- To differentiate the roles of UCP2-UCP5 from the established function of UCP1.
Main Methods:
- Phylogenetic analysis to understand evolutionary relationships.
- Investigation of potential roles in reactive oxygen species handling.
- Exploration of involvement in fatty acid metabolism.
Main Results:
- UCP2 and UCP3 may be involved in reactive oxygen species handling and/or fatty acid metabolism, with uncoupling as a secondary effect.
- Limited information exists for UCP4 and UCP5 (BMCP1).
- Phylogenetic analyses suggest UCP4 and UCP5 are distinct from UCP1 and other mitochondrial anion carriers, implying unique functions.
Conclusions:
- The functions of novel uncoupling proteins (UCP2-UCP5) are distinct from UCP1's thermogenic role.
- UCP2/UCP3 likely play roles beyond simple uncoupling, possibly in redox balance and lipid metabolism.
- Further research is needed to fully characterize UCP4 and UCP5.
Related Concept Videos
01:45Mitochondrial Membranes
A single mitochondrion is a bean-shaped organelle enclosed by a double-membrane system. The outer membrane of mitochondria is smooth and contains many porins - the integral membrane transporters. Porins enable free diffusion of ions and small uncharged molecules through the outer mitochondrial membrane but limit the transport of molecules larger than 5000 Daltons. Further, the outer mitochondrial membrane forms a unique structure called membrane contact sites with other subcellular organelles,...
01:46Electron Transport Chain: Complex I and II
The mitochondrial electron transport chain (ETC) is the main energy generation system in the eukaryotic cells. However, mitochondria also produce cytotoxic reactive oxygen species (ROS) due to the large electron flow during oxidative phosphorylation. While Complex I is one of the primary sources of superoxide radicals, ROS production by Complex II is uncommon and may only be observed in cancer cells with mutated complexes.
ROS generation is regulated and maintained at moderate levels necessary...
ROS generation is regulated and maintained at moderate levels necessary...
01:39Mitochondrial Protein Sorting
Mitochondria are double-membrane organelles of the eukaryotes involved in cellular metabolism, signaling, ATP synthesis, and programmed cell death. Each of these processes requires specific proteins and enzymes that must be correctly sorted to the right mitochondrial subcompartment for the proper functioning of the organelle.
Most of these mitochondrial proteins are encoded by the nucleus and imported to the mitochondria as unfolded or loosely folded precursors. Mitochondrial precursors...
Most of these mitochondrial proteins are encoded by the nucleus and imported to the mitochondria as unfolded or loosely folded precursors. Mitochondrial precursors...
01:19Translocation of Proteins into the Mitochondria
Mitochondrial precursors are translocated to the internal subcompartments via independent mechanisms involving distinct protein machineries called translocases.
Sorting of outer membrane proteins:
Mitochondrial outer membrane proteins are of two types: the transmembrane, beta-barrel porins, and the membrane-anchored, alpha-helical proteins. Beta-barrel porin precursors are translocated by the TOM complex and inserted into the outer mitochondrial membrane by the SAM complex. In contrast,...
Sorting of outer membrane proteins:
Mitochondrial outer membrane proteins are of two types: the transmembrane, beta-barrel porins, and the membrane-anchored, alpha-helical proteins. Beta-barrel porin precursors are translocated by the TOM complex and inserted into the outer mitochondrial membrane by the SAM complex. In contrast,...
01:26Targets for Drug Action: Overview
Drugs target macromolecules to modify ongoing cellular processes. Primary drug targets include receptors, ion channels, transporters, and enzymes.
Receptors are either membrane-spanning or intracellular proteins, which upon binding a ligand, get activated and transmit the signal downstream to elicit a response. Drugs bind receptors, either mimicking the action of endogenous ligands or blocking the receptor activity to bring about a modified response. Nearly 35% of approved drugs target the G...
Receptors are either membrane-spanning or intracellular proteins, which upon binding a ligand, get activated and transmit the signal downstream to elicit a response. Drugs bind receptors, either mimicking the action of endogenous ligands or blocking the receptor activity to bring about a modified response. Nearly 35% of approved drugs target the G...
01:29Pharmacogenomics: Identification of New Drug Targets
Advances in genomics have profoundly influenced drug discovery by increasing both the speed and accuracy of pharmaceutical development. Pharmacogenomics, which examines how genetic variation influences drug response, facilitates the identification of novel therapeutic targets and enables patient stratification for personalized treatment. These strategies contribute to improved drug efficacy, minimized adverse effects, and more efficient clinical trial design.Mapping genetic differences...